From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Dermatology>
  4. Summary and Comment

Hyaluronidase for Fixing Restylane Mistakes

A new strategy to reduce hyaluronic-acid overcorrections

Nonanimal, stabilized hyaluronic acid (NASHA) gels have become a very popular dermal filler material. In the past, if an error was made in filler quantity or placement, the solution was to wait for the material to reabsorb over several months. Hyaluronidase may have the potential to speed resorption by breaking up the gel. To evaluate hyaluronidase's effects on previously implanted NASHA gel, these researchers performed a two-part, prospective, randomized, sequential study.

In the first part, 12 healthy volunteers had 0.2 mL of NASHA gel injected into two sites, approximately 10 cm apart, on one forearm. One to 3 days after implantation, a blinded evaluator graded the cutaneous augmentation at both sites, and 75 units of hyaluronidase with thimerosal preservative were injected into one site and control saline into the other. Within 4 to 7 days of hyaluronidase injection, 80% of the NASHA gel had clinically disappeared at the hyaluronidase site, while 90% of the gel persisted at the control site. Fourteen days later, the median skin score at the hyaluronidase sites was 0 -- no clinically detectable gel.

The second part of the study was designed to measure the dose-dependent effects of hyaluronidase. Eight new volunteers received three 0.2-mL injections of NASHA gel, 3 cm apart, on one forearm. Three to 5 days later, a different concentration of preservative-free hyaluronidase (10, 20, or 30 units) was injected into each of the three implantation sites in each subject. Four to 7 days later, the 30-U sites had no palpable gel, and the 20-U and 10-U sites demonstrated dose-dependent reductions. By 14 days, the 20-U sites became clinically imperceptible, and by 4 weeks, the 10-U sites became imperceptible as well. About 25% of subjects in both parts of the study developed localized allergic reactions in the hyaluronidase-injected sites; the reaction was more pronounced with injections containing thimerosal.

Comment: Hyaluronidase injections were useful in reducing NASHA gel overcorrection. The desired level of flattening can be achieved by carefully titrating the dose, and larger doses completely eliminate NASHA gel effect from the implantation site. The injection can be done several days after implantation, when the procedure-associated edema has mostly resolved. Localized allergic reactions to hyaluronidase were frequent at the doses used. Patients with a history of allergy to bee venom or to the preservative should not be injected.

— George J. Hruza, MD

Published in Journal Watch Dermatology August 9, 2005

Citation(s):

Vartanian AJ et al. Injected hyaluronidase reduces restylane-mediated cutaneous augmentation. Arch Facial Plast Surg 2005 Jul/Aug; 7:231-7.

Reader Remarks:

Read all Reader Remarks on this article

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

(more...)

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2005. Massachusetts Medical Society. All rights reserved.